Different systems. A shared need to make evidence useful.

A hospital pharmacy team may be preparing a formulary evidence case. An ambulatory-care team may need to coordinate the work around an agreed medicines improvement. A community-pharmacy operator may be examining a service that must make sense professionally and commercially.

The practical starting point is the same: what happens today, who performs the work and where effort repeats. A useful evaluation needs a task with consequences and an organisation able to compare the approach fairly. This creates a more credible commercial centre than a broad promise to optimise every drug decision across every payer and provider.

For a hospital or health system, pharmacy leaders and Pharmacy and Therapeutics teams are important participants in formulary work. A software or evaluation purchase also involves the organisation’s authorised budget holder and relevant procurement, digital, privacy and security colleagues.

For an independent pharmacy, the owner or authorised business leader shapes the commercial case, with the relevant professional and state requirements. A health plan or employer may contract with a pharmacy benefit manager for benefit administration. State Medicaid programmes have their own pharmacy and drug-utilisation-review responsibilities. These functions overlap in the medicines journey, but a purchase by one does not confer another organisation’s authority. Map the actual roles before shaping the proposal.

Consider a health-system pharmacy team preparing an evidence case for a Pharmacy and Therapeutics review. The team needs relevant sources, a clear comparison, local operational considerations and a record that qualified reviewers can challenge.

A proposed PHARMORIS evaluation could compare the existing preparation and follow-through with an agreed assisted workflow. Count source checking, corrections, missing information, professional effort and implementation questions. Examine whether the resulting case is useful to the people who receive it. This is an illustrative organisational evaluation; its functions, information and appropriate oversight would be agreed for the setting, rather than presumed from another country’s experience.

Professional responsibilities, working arrangements and relevant requirements vary between US settings and states. The organisational task, intended use and review participants need to be established locally. An attractive demonstration does not resolve those questions.

Our planned evaluation approach asks whether the complete workflow adds useful value compared with competent existing practice. It includes appropriate trust, errors, checking, usability and the burden of introduction. The result should show what is worth developing further and which conditions matter. A narrower use case with a responsible sponsor can provide a stronger starting point than an unsupported claim of national readiness.

We welcome scoped discussions with health-system pharmacy leaders, community-pharmacy businesses, relevant programme teams and evaluation specialists. Tell us which organisational decision needs support and how the work happens today.

A PHARMORIS briefing can examine the fit, the authorised organisation, the proposed comparison and the expertise a possible evaluation requires. The aim is a useful first case shaped for its setting, with a clear reason for both user and buyer to take the next step.